Jo Viney

Two Pan­dion vets jump back in­to the start­up world, this time us­ing ma­chine learn­ing to build bet­ter im­munol­o­gy drugs

As her days as a Mer­ck em­ploy­ee dwin­dled down and the un­cer­tain next step of her ca­reer stared her in the face, Jo Viney felt …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.